JANUS HENDERSON GROUP PLC

Holdings History for Vaxcyte, Inc. - Common Stock (PCVX)

Symbol: PCVX on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock
Latest Disclosed Ownership: 10.6M shares
Security Ownership: 8.5%

Shares, Excluding Options vs Price

Value, Excluding Options

JANUS HENDERSON GROUP PLC ownership in Vaxcyte, Inc. Common Stock (PCVX)

2025-02-14 - JANUS HENDERSON GROUP PLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10.6M shares of Vaxcyte, Inc. Common Stock (PCVX). This represents 8.5% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
JANUS HENDERSON GROUP PLC	8.5%		$399M	10.6M			$37.76	13G/A	12/31/2024	14 Feb 2025 12:12:20

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0.44%	-0.01%	$866M	10.6M	-346,533	-3.17%	$81.85	Q4 2024
9/30/2024	0.64%	+0.12%	$1.25B	10.9M	+2,052,989	+23.1%	$114.26	Q3 2024
6/30/2024	0.36%	+0.05%	$670M	8.87M	+1,195,039	+15.6%	$75.51	Q2 2024
3/31/2024	0.29%	+0.03%	$524M	7.67M	+692,492	+9.92%	$68.30	Q1 2024
12/31/2023	0.26%	0%	$438M	6.98M	-79,212	-1.12%	$62.80	Q4 2023
9/30/2023	0.24%	+0%	$360M	7.06M	+837	+0.01%	$50.97	Q3 2023
6/30/2023	0.22%	0%	$353M	7.06M	-67,860	-0.95%	$49.94	Q2 2023
3/31/2023	0.18%	+0.03%	$267M	7.13M	+1,153,472	+19.3%	$37.48	Q1 2023
12/31/2022	0.2%	+0.05%	$286M	5.97M	+1,436,388	+31.7%	$47.95	Q4 2022
9/30/2022	0.08%	+0.01%	$109M	4.54M	+313,264	+7.42%	$24.00	Q3 2022
6/30/2022	0.06%	0%	$91.9M	4.22M	-105,277	-2.43%	$21.76	Q2 2022
3/31/2022	0.05%	+0%	$105M	4.33M	+83,100	+1.96%	$24.15	Q1 2022
12/31/2021	0.04%	+0%	$101M	4.25M	+153,198	+3.74%	$23.79	Q4 2021
9/30/2021	0.05%	0%	$104M	4.09M	-23,493	-0.57%	$25.37	Q3 2021
6/30/2021	0.04%	0%	$92.7M	4.12M	-113,348	-2.68%	$22.51	Q2 2021
3/31/2021	0.04%	+0%	$83.5M	4.23M	+33,529	+0.8%	$19.75	Q1 2021
12/31/2020	0.05%	+0%	$108M	4.2M	+349	+0.01%	$25.62	Q4 2020
9/30/2020	0.1%	-0.01%	$200M	4.2M	-529,363	-11.2%	$47.62	Q3 2020
6/30/2020	0.08%	+0.08%	$140M	4.73M	+4,725,792	NEW	$29.61	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.